ClinicalTrials.govpublic full text
A Study of MRG002 Versus Investigator's Choice of Chemotherapy in the Treatment of Patients With HER2-positive Unresectable Advanced or Metastatic Urothelial Cancer
advanced or metastatic urothelium cancer, mrg002, antibody drug conjugate (adc), her2, urothelium cancer, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 968863
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.